Article: Acute Lymphoblastic Leukemia as Secondary Malignancy in a Case of Ewing's Sarcoma on Treatment.
2017 Volume 38, Issue 3, Page(s) 354–356
Abstract: The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which can be in the form of solid tumors and hematological malignancies. The ...
| Abstract | The survival of Ewing's sarcoma (ES) has improved due to advances in both local and systemic therapy. This has given rise to an increased detection of second malignant neoplasms which can be in the form of solid tumors and hematological malignancies. The most common hematological malignancies are acute myeloid leukemia/myelodysplastic syndrome. Acute lymphoblastic leukemia (ALL) is relatively uncommon in occurrence in this setting. Furthermore, the average refractory period for hematological malignancies varies from 3 to 5 years. We report a case of a young female who developed ALL while on adjuvant therapy for ES. |
|---|---|
| Language | English |
| Publishing date | 2017-07-25 |
| Publishing country | India |
| Document type | Case Reports |
| ZDB-ID | 2181724-8 |
| ISSN | 0975-2129 ; 0971-5851 |
| ISSN (online) | 0975-2129 |
| ISSN | 0971-5851 |
| DOI | 10.4103/ijmpo.ijmpo_110_16 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.